Rotenone decreases ischemia-induced injury by inhibiting mitochondrial permeability transition in mature brains

Evelina Rekuviene1, Laima Ivanoviene1, Vilmante Borutaite2

  • 1Department of Biochemistry, Lithuanian University of Health Sciences, Eiveniu 4, LT-50161 Kaunas, Lithuania.

Insights

Rotenone, a complex I inhibitor, protects adult rat brains from ischemia-induced cell death by preventing mitochondrial permeability transition pore (mPTP) opening and reducing reactive oxygen species (ROS) production. This suggests complex I plays a key role in regulating mPTP during cerebral ischemia.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Biochemistry

Background:

  • Mitochondrial permeability transition pore (mPTP) opening is implicated in brain ischemia-induced cell death.
  • The role of mitochondrial electron transport chain complex I (CI) in mPTP regulation during ischemia is not fully understood.

Purpose of the Study:

  • To investigate the involvement of CI in mPTP regulation during ischemia.
  • To determine if rotenone, a CI inhibitor, protects against ischemia-induced cell death in a rat brain model.

Main Methods:

  • Adult Wistar rats received intravenous rotenone before induced brain ischemia.
  • Mitochondria were isolated from brain regions (cortex, cerebellum) post-ischemia.
  • Calcium-induced mPTP opening and reactive oxygen species (ROS) production were measured.
  • Infarct size was assessed in brain regions.

Main Results:

  • Rotenone administration increased resistance to Ca2+-induced mPTP opening.
  • Rotenone decreased ROS production in isolated mitochondria.
  • Rotenone significantly reduced infarct size in both cortex and cerebellum.
  • Rotenone inhibited NAD-dependent mitochondrial respiration.

Conclusions:

  • Rotenone exhibits protective effects against acute brain ischemia-induced injuries by inhibiting mPTP opening and ROS production.
  • CI of the mitochondrial electron transfer system is involved in mPTP regulation during cerebral ischemia.
  • Agents targeting CI activity may offer potential therapeutic strategies for stroke treatment.